journal article·2018-02-12

Gradient-on-a-Chip with Reactive Oxygen Species Reveals Thresholds in the Nucleus Response of Cancer Cells Depending on the Matrix Environment

Shirisha Chittiboyina, Rahim Rahimi, Farzaneh Atrian, Manuel Ochoa, Babak Ziaie, Sophie A. Lelièvre

Publisher page

Abstract

Oxidative stress-mediated cancer progression depends on exposure to reactive oxygen species (ROS) in the extracellular matrix (ECM). To study the impact of ROS levels on preinvasive breast cancer cells as a function of ECM characteristics, we created a gradient-on-a-chip in which H 2 O 2 progressively mixes with the cell culture medium within connected microchannels and diffuses upward into the ECM of the open cell culture window. The device utilizes a paper-based microfluidic bifurcating mixer insert to prevent leakage and favor an even fluid distribution. The gradient was confirmed by measuring H 2 O 2 catalyzed into oxygen, and increasing oxidative DNA damage and protective (AOP2) response were recorded in 2D and ECM-based 3D cell cultures. Interestingly, the impact of ROS on nuclear shape and size (annunciating phenotypical changes) was governed by the stiffness of the collagen I matrix, suggesting the existence of thresholds for the phenotypic response to microenvironmental chemical exposure depending on ECM conditions.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Cellular Mechanics and Interactions · Cancer Cells and Metastasis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Basic Medical Sciences, 625 Harrison Street, Purdue University, West Lafayette, Indiana 47907, United States

Department of Electrical and Computer Engineering, 465 Northwestern Avenue, Purdue University, West Lafayette, Indiana 47907, United States

Birck Nanotechnology Center, Purdue University, 1205 W State Street, Purdue Discovery Park, West Lafayette, Indiana 47907, United States

Purdue University Center for Cancer Research, Purdue University, 201 South University Street, West Lafayette, Indiana 47907, United States

Funding

Office of Executive Vice President for Research and Partnership, Purdue University

References (46)

Show source-provided references
1. 10.1016/0045-6039(85)90481-610.1016/0045-6039(85)90481-6 ↗
2. 10.1126/science.109092210.1126/science.1090922 ↗
3. 10.1016/j.semcancer.2005.06.00910.1016/j.semcancer.2005.06.009 ↗
4. 10.1016/j.drudis.2012.10.00310.1016/j.drudis.2012.10.003 ↗
5. 10.1016/0955-0674(93)90088-810.1016/0955-0674(93)90088-8 ↗
6. 10.1016/0955-0674(95)80117-010.1016/0955-0674(95)80117-0 ↗
7. 10.1073/pnas.95.25.1471110.1073/pnas.95.25.14711 ↗
8. 10.1038/nrg81610.1038/nrg816 ↗
9. 10.1016/B978-0-12-407190-2.00003-410.1016/B978-0-12-407190-2.00003-4 ↗
10. 10.1042/BST039127910.1042/BST0391279 ↗
11. 10.1097/00044067-200211000-0000710.1097/00044067-200211000-00007 ↗
12. 10.1016/j.dnarep.2004.03.00210.1016/j.dnarep.2004.03.002 ↗
13. 10.1101/cshperspect.a00322810.1101/cshperspect.a003228 ↗
14. 10.1016/j.ceb.2014.01.00310.1016/j.ceb.2014.01.003 ↗
15. 10.1007/s10544-006-9005-710.1007/s10544-006-9005-7 ↗
16. 10.1039/b804485f10.1039/b804485f ↗
17. 10.1007/BF0262357810.1007/BF02623578 ↗
18. 10.1023/A:100643450306110.1023/A:1006434503061 ↗
19. Briand P. · Cancer Res. · 1996 · 56 · 2039
20. 10.1007/978-1-62703-125-7_1310.1007/978-1-62703-125-7_13 ↗
21. 10.1016/j.yexcr.2004.04.02410.1016/j.yexcr.2004.04.024 ↗
22. 10.1091/mbc.E06-06-055110.1091/mbc.E06-06-0551 ↗
23. 10.1158/0008-5472.CAN-07-222510.1158/0008-5472.CAN-07-2225 ↗
24. 10.1385/MO:22:1:01110.1385/MO:22:1:011 ↗
25. 10.1038/jid.2014.9010.1038/jid.2014.90 ↗
26. 10.1016/j.ccr.2005.08.01010.1016/j.ccr.2005.08.010 ↗
27. 10.1016/j.jsb.2009.05.00510.1016/j.jsb.2009.05.005 ↗
28. 10.1073/pnas.89.19.906410.1073/pnas.89.19.9064 ↗
29. 10.1242/jcs.0343910.1242/jcs.03439 ↗
30. 10.1080/1059050090288568410.1080/10590500902885684 ↗
31. 10.1002/cyto.a.2232710.1002/cyto.a.22327 ↗
32. 10.1074/jbc.M10073320010.1074/jbc.M100733200 ↗
33. 10.1038/emboj.2011.49210.1038/emboj.2011.492 ↗
34. 10.1371/journal.pone.011096310.1371/journal.pone.0110963 ↗
35. Giardina C. · J. Exp. Clin. Cancer Res. · 2003 · 22 · 279
36. 10.1242/jcs.03733310.1242/jcs.037333 ↗
37. 10.1152/physiolgenomics.00060.200510.1152/physiolgenomics.00060.2005 ↗
38. 10.1007/s10544-013-9737-010.1007/s10544-013-9737-0 ↗
39. 10.1016/j.biomaterials.2015.02.01210.1016/j.biomaterials.2015.02.012 ↗
40. 10.1042/BST035114710.1042/BST0351147 ↗
41. 10.1038/nrc143010.1038/nrc1430 ↗
42. Lelièvre S. A. · 2014 · 494
43. Li J. J. · Oncogene · 1995 · 10 · 1989
44. 10.1002/cphy.c10003810.1002/cphy.c100038 ↗
45. 10.1016/j.crad.2016.09.01310.1016/j.crad.2016.09.013 ↗
46. 10.1039/C3LC50819F10.1039/C3LC50819F ↗